Moderna's COVID-19 vaccine shows promise against Delta variant in lab study

14 Sept 13:33 Key points summarised by AI

Moderna's COVID-19 vaccine (mRNA-1273) demonstrated effectiveness against the Delta variant in a lab study, showing a modest decrease in antibody response compared to the original strain.
The vaccine produced an antibody response against all tested variants, proving significantly more effective against the Delta variant than against the Beta variant.
Moderna's CEO expressed confidence that the vaccine should remain protective against newly detected variants, reinforcing its broad efficacy.
India has granted permission to Cipla Ltd to import Moderna's vaccine for restricted use, indicating its expanding global reach.

Uthenthawai students and alumni declare truce with Pathumwan rivals

Yesterday 20:34 Key points summarised by AI

Uthenthawai students and alumni have pledged to cease violent clashes with Pathumwan Institute rivals, coinciding with their campus's reopening after a 90-day closure.
The Minister of Higher Education is mediating the long-running conflict, while the campus closure has significantly disrupted in-person classes and laboratory work for over 1,000 students.
Uthenthawai resists relocation from its current site, citing a historical land grant from King Rama VI, despite Chulalongkorn University's plans to reclaim the land for an educational hub.
Concerns are mounting over the legality of the campus closure, its detrimental impact on uninvolved students, and the potential commercial development of the land, which critics argue contradicts the late King Rama VI's intentions.